These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24930219)

  • 41. [The Cutting-edge of Medicine; Human gut microbiome and its implication in endocrinology and metabolism].
    Irie J; Itoh H
    Nihon Naika Gakkai Zasshi; 2014 Nov; 103(11):2813-9. PubMed ID: 27522824
    [No Abstract]   [Full Text] [Related]  

  • 42. Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.
    Prattichizzo F; Giuliani A; Mensà E; Sabbatinelli J; De Nigris V; Rippo MR; La Sala L; Procopio AD; Olivieri F; Ceriello A
    Ageing Res Rev; 2018 Dec; 48():87-98. PubMed ID: 30336272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Metabolic Role of the Microbiome: Implications for NAFLD and the Metabolic Syndrome.
    Quigley EM; Abu-Shanab A; Murphy EF; Stanton C; Monsour HP
    Semin Liver Dis; 2016 Sep; 36(4):312-316. PubMed ID: 27997970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Metabolic syndrome and intestinal microflora: what overall?].
    Plotnikova EIu; Krasnov OA
    Eksp Klin Gastroenterol; 2014; (12):64-73. PubMed ID: 26058115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does the gut microbiome hold clues to obesity and diabetes?
    Gross M
    Curr Biol; 2013 May; 23(9):R359-62. PubMed ID: 23802281
    [No Abstract]   [Full Text] [Related]  

  • 46. Intestinal Ralstonia pickettii augments glucose intolerance in obesity.
    Udayappan SD; Kovatcheva-Datchary P; Bakker GJ; Havik SR; Herrema H; Cani PD; Bouter KE; Belzer C; Witjes JJ; Vrieze A; de Sonnaville ESV; Chaplin A; van Raalte DH; Aalvink S; Dallinga-Thie GM; Heilig HGHJ; Bergström G; van der Meij S; van Wagensveld BA; Hoekstra JBL; Holleman F; Stroes ESG; Groen AK; Bäckhed F; de Vos WM; Nieuwdorp M
    PLoS One; 2017; 12(11):e0181693. PubMed ID: 29166392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
    Han JL; Lin HL
    World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.
    Shin NR; Lee JC; Lee HY; Kim MS; Whon TW; Lee MS; Bae JW
    Gut; 2014 May; 63(5):727-35. PubMed ID: 23804561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polysaccharides from Laminaria japonica alleviated metabolic syndrome in BALB/c mice by normalizing the gut microbiota.
    Duan M; Sun X; Ma N; Liu Y; Luo T; Song S; Ai C
    Int J Biol Macromol; 2019 Jan; 121():996-1004. PubMed ID: 30342121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intestinal microbiota and obesity.
    Blaut M; Klaus S
    Handb Exp Pharmacol; 2012; (209):251-73. PubMed ID: 22249818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet.
    Candela M; Biagi E; Soverini M; Consolandi C; Quercia S; Severgnini M; Peano C; Turroni S; Rampelli S; Pozzilli P; Pianesi M; Fallucca F; Brigidi P
    Br J Nutr; 2016 Jul; 116(1):80-93. PubMed ID: 27151248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diet, gut microbiota and cognition.
    Proctor C; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2017 Feb; 32(1):1-17. PubMed ID: 27709426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.
    Caesar R
    Can J Diabetes; 2019 Apr; 43(3):224-231. PubMed ID: 30929665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus.
    Allin KH; Nielsen T; Pedersen O
    Eur J Endocrinol; 2015 Apr; 172(4):R167-77. PubMed ID: 25416725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fecal microbiota transplantation in metabolic syndrome: History, present and future.
    de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M
    Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New aspects of Helicobacter pylori infection: Association with metabolic disturbances].
    German SV; Bobrovnitsky IP
    Ter Arkh; 2017; 89(10):102-107. PubMed ID: 29171479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic Syndrome.
    Paleari L; Burhenne J; Weiss J; Foersch S; Roth W; Parodi A; Gnant M; Bachleitner-Hofmann T; Scherer D; Ulrich CM; Stabuc B; Puntoni M; Coccia G; Petrera M; Haefeli WE; DeCensi A
    Gastroenterology; 2018 Apr; 154(5):1543-1545. PubMed ID: 29526732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.